SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    V. Virlogeux, P. Pradat, F. Bailly, G. Funingana, F. Gonçalves, M. Maynard, K. Hartig-Lavie, M. Amiri, F. Zoulim, Boceprevir and telaprevir-based triple therapy for chronic hepatitis C: virological efficacy and impact on kidney function and model for end-stage liver disease score, Journal of Viral Hepatitis, 2014, 21, 8
  2. 2
    DL Braun, A Rauch, N Durisch, N Eberhard, A Anagnostopoulos, B Ledergerber, KJ Metzner, J Böni, R Weber, J Fehr, Efficacy of lead-in silibinin and subsequent triple therapy in difficult-to-treat HIV/hepatitis C virus-coinfected patients, HIV Medicine, 2014, 15, 7
  3. 3
    D. S. Fierer, D. T. Dieterich, M. P. Mullen, A. D. Branch, A. J. Uriel, D. C. Carriero, W. O. van Seggelen, R. M. Hijdra, D. G. Cassagnol, B. Akil, J. Bailey, P. Bellman, D. Bowers, K. Bungay, S. Burger, W. Carpenter, R. Chavez, R. Chow, R. Cohen, P. Dalton, J. Dellosso, A. Demidont, S. Dillon, E. Donlon, T. Farrow, D. Gardenier, R. Guadron, S. Haber, L. Higgins, L. Hitzeman, R. Hsu, S. Huprikar, V. Inada, S. Jacob, L. Johnson, B. Johnston, D. Kaminsky, O. Klein, J. Kwong, J. Lares-Guia, E. Leach, R. Levine, I. Linetskaya, L. Litvinova, A. Malhotra, W. Mandell, M. Markowitz, G. Mayer, E. Meraz, E. Mortensen, M. Ng, J. Olivieri, C. Paolino, P. Photangtham, G. Psevdos, A. Radix, S. Rapaport, G. Rodriguez-Caprio, W. Shay, N. Somasundaram, L. Sorra, A. Stivala, R. Tran, A. Urbina, R. Vail, F. Wallach, W. Wang, S. Weiss, M. Wiener, Telaprevir in the Treatment of Acute Hepatitis C Virus Infection in HIV-Infected Men, Clinical Infectious Diseases, 2014, 58, 6, 873

    CrossRef

  4. 4
    Dominique Salmon-Ceron, Cédric Arvieux, Marc Bourlière, Patrice Cacoub, Philippe Halfon, Karine Lacombe, Georges-Philippe Pageaux, Gilles Pialoux, Lionel Piroth, Isabelle Poizot-Martin, Eric Rosenthal, Stanislas Pol, Use of first-generation HCV protease inhibitors in patients coinfected by HIV and HCV genotype 1, Liver International, 2014, 34, 6
  5. 5
    Carmen Vinaixa, Victoria Aguilera, Marina Berenguer, Avances en el tratamiento de la hepatitis C, Medicina Clínica, 2013, 141, 10, 447

    CrossRef

  6. 6
    E. Lontok, N. Mani, P. R. Harrington, V. Miller, Closing in on the Target: Sustained Virologic Response in Hepatitis C Virus Genotype 1 Infection Response-Guided Therapy, Clinical Infectious Diseases, 2013, 56, 10, 1466

    CrossRef

  7. 7
    Gustaf Ahlén, Lars Frelin, Erwin Daniel Brenndörfer, Anette Brass, Ola Weiland, Margaret Chen, Matti Sällberg, Containing “The Great Houdini” of viruses: Combining direct acting antivirals with the host immune response for the treatment of chronic hepatitis C, Drug Resistance Updates, 2013, 16, 3-5, 60

    CrossRef

  8. 8
    John M. Vierling, Hepatitis C Virus Viral Assays in the Direct-Acting Antiviral Era, Clinics in Liver Disease, 2013, 17, 1, 27

    CrossRef

  9. 9
    Pablo Barreiro, Pablo Labarga, José V. Fernández-Montero, Eva Poveda, Carmen de Mendoza, Clara Sánchez, Eugenia Vispo, Vincent Soriano, Longitudinal changes in viral RNA concentration in patients with chronic hepatitis C and/or HIV infection in the absence of antiviral therapy, Journal of Clinical Virology, 2013, 58, 2, 391

    CrossRef